Robert J. Ihry
0000-0003-4519-3136
Publication & Citation Trends
Publications
0 total
Enhancing the Small-Scale Screenable Biological Space beyond Known Chemogenomics Libraries with Gray Chemical Matter—Compounds with Novel Mechanisms from High-Throughput Screening Profiles OA
Cited by 5
Semantic Scholar
DRUG-seq Provides Unbiased Biological Activity Readouts for Neuroscience Drug Discovery OA
Cited by 25
Semantic Scholar
TRAWLING: a Transcriptome Reference Aware of spLIciNG events OA
Cited by 0
Semantic Scholar
Patient Brain Organoids Identify a Link between the 16p11.2 Copy Number Variant and the RBFOX1 Gene OA
Cited by 8
Semantic Scholar
Genome-Scale CRISPR Screens Identify Human Pluripotency-Specific Genes. OA
Cited by 67
Semantic Scholar
DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery OA
Cited by 176
Semantic Scholar
p 53 inhibits CRISPR – Cas 9 engineering in human pluripotent stem cells
Cited by 71
Semantic Scholar
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells OA
Cited by 842
Semantic Scholar
Research Topics
CRISPR and Genetic Engineering
(9)
Pluripotent Stem Cells Research
(5)
Single-cell and spatial transcriptomics
(5)
Computational Drug Discovery Methods
(4)
Cell Image Analysis Techniques
(4)
Affiliations
Genomics Institute of the Novartis Research Foundation
Novartis (Switzerland)
University of Wisconsin–Madison
Novartis (France)
Novartis (United States)